Literature DB >> 24894535

Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.

M Niebuhr1, K Baumert, A Heratizadeh, I Satzger, T Werfel.   

Abstract

BACKGROUND: Atopic dermatitis (AD) and psoriasis patients are frequently colonized with Staphylococcus aureus (S. aureus) that produce the staphylococcal exotoxin α-toxin. However, only patients with AD suffer from bacterial superinfections with this pathogen, which implicates immunological differences in AD vs psoriasis in combating these bacteria. S. aureus recognition is partially mediated by intracellular nucleotide-binding oligomerization domain receptors (NLRs), which link α-toxin to caspase-1 activation through the formation of the NLRP3 inflammasome and to IL-1β secretion.
OBJECTIVE: To investigate (i) NLRP3 expression in the context of different T-helper cytokine milieus and (ii) its function in response to sublytic α-toxin stimulation in patients with AD and psoriasis compared with healthy controls.
METHODS: NLRP3 expression and function were investigated in lesional AD and psoriasis skin as well as in primary keratinocytes (HPKs) and monocytes upon stimulation with Th1, Th2, Th17 and Th22 cytokines or staphylococcal α-toxin, respectively, at the mRNA and protein (ELISA, immunohistochemistry and immunofluorescence) level.
RESULTS: NLRP3 and caspase-1 expressions were reduced in lesional AD skin compared to psoriatic and healthy skin. IL-4, IL-5 and IL-13 downregulated NLRP3 and ASC, whereas interferon-γ upregulated NLRP3 in HPKs. In monocytes, caspase-1 expression was reduced by Th2 cytokines and enhanced by a Th1 milieu. Caspase-1-dependent IL-1β secretion was impaired in monocytes from patients with AD compared to patients with psoriasis and healthy controls by α-toxin stimulation following priming with lipoteichoic acid.
CONCLUSION: Impaired NLRP3 expression and function may partially explain how skin colonization and infection with S. aureus can contribute to chronic skin inflammation in AD.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NLRP3; atopic dermatitis; lipoteichoic acid; psoriasis; α-toxin

Mesh:

Substances:

Year:  2014        PMID: 24894535     DOI: 10.1111/all.12428

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  25 in total

1.  Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior.

Authors:  Matthew G Frank; Laura K Fonken; Samuel D Dolzani; Jessica L Annis; Philip H Siebler; Dominic Schmidt; Linda R Watkins; Steven F Maier; Christopher A Lowry
Journal:  Brain Behav Immun       Date:  2018-05-26       Impact factor: 7.217

2.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

3.  Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation.

Authors:  Adnan K Syed; Tamra J Reed; Kaitlyn L Clark; Blaise R Boles; J Michelle Kahlenberg
Journal:  Infect Immun       Date:  2015-06-15       Impact factor: 3.441

Review 4.  Inflammasome Activation Can Mediate Tissue-Specific Pathogenesis or Protection in Staphylococcus aureus Infection.

Authors:  Jason H Melehani; Joseph A Duncan
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

5.  Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections.

Authors:  Qi Liu; Momina Mazhar; Lloyd S Miller
Journal:  Curr Dermatol Rep       Date:  2018-09-22

6.  An Allergic Lung Microenvironment Suppresses Carbon Nanotube-Induced Inflammasome Activation via STAT6-Dependent Inhibition of Caspase-1.

Authors:  Kelly A Shipkowski; Alexia J Taylor; Elizabeth A Thompson; Ellen E Glista-Baker; Brian C Sayers; Zachary J Messenger; Rebecca N Bauer; Ilona Jaspers; James C Bonner
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 7.  Inflammasomes and dermatology.

Authors:  Daniel Coelho de Sá; Cyro Festa
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

Review 8.  Bacterial Exotoxins and the Inflammasome.

Authors:  Allison J Greaney; Stephen H Leppla; Mahtab Moayeri
Journal:  Front Immunol       Date:  2015-11-10       Impact factor: 7.561

Review 9.  Skin barrier in atopic dermatitis: beyond filaggrin.

Authors:  Mariana Colombini Zaniboni; Luciana Paula Samorano; Raquel Leão Orfali; Valéria Aoki
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

10.  NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis.

Authors:  Shigehiro Itani; Toshio Watanabe; Yuji Nadatani; Naoki Sugimura; Sunao Shimada; Shogo Takeda; Koji Otani; Shuhei Hosomi; Yasuaki Nagami; Fumio Tanaka; Noriko Kamata; Hirokazu Yamagami; Tetsuya Tanigawa; Masatsugu Shiba; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.